Biotech and Healthcare investors in Europe
102 funds · Updated
Gatsbie lists 102 Biotech and Healthcare investors headquartered in Europe (as of 2026-11-18).
Each one names both biotech & life sciences and healthcare & medtech in its investment focus.
Most are based in United Kingdom (33), Germany (13) and France (11); the most common stages are Seed (84), Series A (82) and Pre-Seed (66); the most common kinds of capital are Venture equity (92), Growth equity (42) and Buyout (23).
Which Biotech and Healthcare investors are based in Europe?
Gatsbie lists 102 Biotech and Healthcare investors headquartered in Europe (as of 2026-11-18). Most are in United Kingdom (33), Germany (13) and France (11). They include Development Partners International (London), Claret Capital Partners (London), Redalpine Venture Partners AG (Zürich), Air Street Capital (London), BlueYard (Berlin) and Eight Roads Ventures (London). Most deals on record in the last 24 months: Development Partners International (3 deals), Claret Capital Partners (2 deals) and Redalpine Venture Partners AG (1 deal).
Which family offices invest in Biotech and Healthcare in Europe?
9 of the 102 Biotech and Healthcare investors on Gatsbie are family offices, including Alychlo, INTERGROUP PARTNERS AG, RTAventures VC, CC TRUST GROUP AG / CLAUDIO CISULLO and CREADEV.
Upload your deck to see which of these fit your startup, with a written reason for each.
20 of 102 funds
Most active first: deals in the last 24 months, then portfolio companies on record.
| # | Fund | HQ | Stages | Partner emails |
|---|---|---|---|---|
| 1 | Development Partners International | London | Seed–Series C+ | 10 |
| 2 | Claret Capital Partners | London | Pre-Seed–Series A, Growth | 15 |
| 3 | Redalpine Venture Partners AG | Zürich | Pre-Seed–Series A, Series C+ | 12 |
| 4 | Air Street Capital | London | Pre-Seed–Series B | 1 |
| 5 | BlueYard | Berlin | Pre-Seed–Series A, Series C+ | 12 |
| 6 | Eight Roads Ventures | London | Seed–Series C+ | 11 |
| 7 | Andera Partners | Paris | Seed–Series C+ | 71 |
| 8 | Iq Capital Partners Llp | Cambridge | Pre-Seed–Series A, Growth | 12 |
| 9 | Seventure Partners | Paris | Seed–Series C+ | 8 |
| 10 | Amino Collective | Berlin | Seed, Series A | 6 |
| 11 | Hummingbird Ventures | London | Pre-Seed–Series B | 12 |
| 12 | MVM Life Science Partners | London | Pre-Seed–Series B | 17 |
| 13 | Practica Capital | Vilnius | Pre-Seed–Series A | 7 |
| 14 | PMV (Participatiemaatschappij Vlaanderen) | Brussels | Pre-Seed–Series B | 34 |
| 15 | Cambridge Innovation Capital | Cambridge | Seed–Series B, Growth | 27 |
| 16 | Outsized Ventures | London | Pre-Seed–Series B | 2 |
| 17 | Alychlo | Merelbeke | Growth | 5 |
| 18 | Amethis | Paris | Growth | 8 |
| 19 | Backed VC | London | Pre-Seed–Series A | 4 |
| 20 | CDP Venture Capital SGR | Rome | Pre-Seed–Series A, Growth | 10 |
See more Biotech and Healthcare investors in Investor Discovery
Other sector pairs
Biotech and Healthcare investors elsewhere
Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.
